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Aquaporin-1 (AQP1) water channels are expressed widely in
microvascular endothelia outside of the central nervous
system, including renal vasa recta and tumor microvessels, as
well as in non-vascular endothelia in pleura, peritoneum,
cornea, and lymphatics. In kidney, AQP1-facilitated water
transport in outer medullary descending vasa recta is likely
an important component of the urinary concentrating
mechanism. However, in most vascular endothelia outside of
kidney, it remains uncertain whether AQP1 expression and
high water permeability are physiologically important. AQP1
in non-vascular endothelia at the inner corneal surface is
involved in the maintenance of corneal transparency.
Recently, a new role of AQP1 in endothelial cell migration
was discovered in analyzing the cause of defective tumor
angiogenesis in AQP1-deficient mice. AQP1 facilitates
endothelial cell migration by a mechanism that may involve
facilitated water transport across cell protrusions
(lamellipodia). AQP1 inhibitors may thus have aquaretic and
antiangiogenic activity.
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The water channel aquaporin-1 (AQP1) is expressed strongly
throughout microvascular endothelia outside of the central
nervous system, such in kidney (vasa recta), lung, skin,
secretory glands, skeletal muscle, pleura, and peritoneum.1,2
AQP1is also expressed strongly in endothelia of tumor
microvessels, and in various non-vascular endothelial cells in
the eye (cornea and canal of Schlemm) and lymphatics
(intestinal lacteals). Figure 1a shows AQP1 immunofluore-
scence in endothelial cells in various microvascular and non-
vascular endothelia. Aquaporins have not been identified in
endothelial cells in the central nervous system, although a
different aquaporin (AQP4) is expressed in astrocyte foot
processes that comprise the blood–brain barrier in close
contact with endothelial cells. The expression of AQP1 in
various vascular and non-vascular endothelia suggests their
involvement in osmotically driven transendothelial water
movement. Utilizing AQP1 knockout mice generated by our
lab in 1998,3 we have investigated the potential roles of
AQP1 in endothelial cell biology. The mouse studies
have indicated several interesting and in some cases
unanticipated phenotypes, including recent evidence for
involvement of AQP1 in tumor angiogenesis and endothelial
cell migration.4
AQP1 IN THE URINARY CONCENTRATING MECHANISM
AQP1-null mice manifest a profound urinary concentrating
defect with polyuria, reduced urinary osmolality, and
vasopressin insensitivity,3 qualitatively similar to that found
in humans lacking AQP1.5 AQP1 is expressed in micro-
vascular endothelia of outer medullary descending vasa recta
(OMDVR). The formation of a concentrated urine requires
the trapping of NaCl and urea in the renal medulla, as well as
efficient near-isosmolar water transport in proximal tubule
and high collecting duct water permeability. In portions of
OMDVR, water efflux occurs despite the existence of Starling
forces (hydrostatic and oncotic forces) that favor volume
influx, suggesting that water efflux involves a water-only
(AQP1) pathway in which NaCl and urea osmotic gradients
drive water movement. Interestingly, OMDVR from AQP1-
null mice are larger in diameter than those of wild-type mice
(Figure 1b), which may represent a chronic compensatory
effect of high blood flow. In vitro microperfusion of OMDVR
showed a more than 10-fold reduced osmotic water
permeability in AQP1 deficiency in response to a 200 mM
NaCl gradient (bath4lumen), and B2-fold reduced water
permeability when driven by a raffinose gradient.6 Together
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with mercurial inhibition measurements, it was concluded
that the majority of NaCl-driven water transport occurs by a
transcellular route through AQP1. In a mathematical model
of the medullary microcirculation, deletion of AQP1 resulted
in diminished concentrating ability due to enhancement of
medullary blood flow, partially accounting for the observed
urinary concentrating defect. Thus AQP1 in OMDVR is likely
an important component of the urinary concentrating
mechanism. Mechanistically, NaCl and urea gradients drive
water transport from the OMDVR lumen to the medullary
interstitium across AQP1, thereby shunting blood flow from
descending to ascending vasa recta in the outer medulla. The
reduced blood flow to the deep inner medullary portions of
the vasa recta is predicted to enhance countercurrent
exchange by limiting solute washout. However, definitive
proof of the involvement of vasa recta AQP1 in the urinary
concentrating mechanism would require tissue-specific AQP1
gene deletion, as AQP1 is also expressed in epithelia of
proximal tubule and thin descending limb of Henle, where it
is of clear functional significance.7,8
AQP1 IN LUNG MICROVESSELS
Water movement in the lung and airways occurs during
airway hydration, absorption of alveolar fluid in the neonatal
period, and formation/resolution of pulmonary edema in
heart failure or lung injury. The barriers to water movement
between the airspace and capillary compartments consist of
an epithelium, interstitium, and endothelium. The alveolar
epithelium is composed mainly of type I cells that express
AQP5 at their apical membrane. The microvascular en-
dothelium expresses AQP1. AQP3 and AQP4 are expressed
mainly in airway epithelia. Isolated perfused lung measure-
ment in knockout mice showed B10-fold reduced osmotic
water permeability after deletion of AQP1 or AQP5
individually, and 430-fold reduced water permeability by
deletion of AQP1 and AQP5 together.9 However, there was
no effect of AQP1 or AQP5 deletion on alveolar fluid
absorption in the adult or neonatal lung, or in the response
of the adult lung to epithelial or endothelial cell injury.
Further, deletion of various aquaporins did not impair airway
humidification or airway surface liquid homeostasis.10
Therefore, although AQP1 in lung/airway microvascular
endothelia facilitates osmotically driven water transport, its
deletion does not impair physiologically relevant lung fluid
transport.
AQP1 AT THE PLEURAL AND PERITONEAL BARRIERS
A similar conclusion came from phenotype studies of AQP1-
deficient mice with regard to pleural and peritoneal fluid
transport – that although AQP1 facilitates osmotic water
transport across these barriers, it did not appear to play a role
in physiologically important fluid absorption or secretion. In
pleura, fluid is continuously secreted into and cleared from
the pleural space, and can accumulate in conditions such as
congestive heart failure and lung infection and tumor. Fluid
entry into the pleural space involves filtration across
microvascular endothelia near the pleural surface and
movement across a mesothelial barrier lining the pleural
space, whereas fluid clearance occurs primarily by lymphatic
drainage. AQP1 is expressed in microvascular endothelia near
the visceral and parietal pleura as well as in mesothelial cells
in visceral pleura.11 In anesthetized, ventilated mice chal-
lenged by instillation of hypertonic or hypotonic fluid into
the pleural space, osmotic equilibration of pleural fluid was
rapid (50% equilibration ino2 min) and slowed byB4-fold
in AQP1-null mice. However, the clearance of isosmolar
saline instilled in the pleural space was not affected by
AQP1 deletion, nor was the accumulation of pleural
fluid in a volume overload model of congestive heart
failure.
Similar studies were carried out in peritoneum, which
consists of a membranous barrier for fluid movement
between peritoneal capillaries and the peritoneal cavity.12
Ascites can accumulate in conditions associated with
decreased serum oncotic pressure, increased portal venous
pressure, or peritoneal cavity inflammation/infection. AQP1
is expressed in capillary endothelia and mesangium near the
peritoneal luminal surface. Peritoneal fluid infusions showed
B2.5-fold reduced osmotic water permeability in AQP1-null
mice; however, fluid absorption after intraperitoneal saline
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Figure 1 | AQP1 expression in endothelial cells in mice. (a)
Immunofluorescence using purified polyclonal anti-AQP1 antibody.
Arrows point to central lacteals in duodenum, corneal endothelia,
pleural microvessels, and skeletal muscle microvessels. (b) Light
micrographs of renal vasa recta microdissected from mouse kidney of
wild-type and AQP1-null mice.
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infusion was not impaired. We concluded that AQP1 is not
an important determinant of peritoneal fluid movement
under physiological conditions, although it does provide the
water-only pathway for fluid clearance in peritoneal dialysis
where water is osmotically extracted into the peritoneal fluid
by hyperosmolar dialyzate solutions.
AQP1 IN OCULAR ENDOTHELIA
AQP1 is expressed in corneal endothelial cells that line the
inner corneal surface, and in trebecular meshwork endothelia
that comprise the aqueous outflow pathway in the canal of
Schlemm. Interestingly, although corneas in AQP1-null mice
are transparent, their thickness is B20% reduced compared
to those in wild-type mice.13 In vivo exposure of the corneal
endothelial surface to hypotonic saline by anterior chamber
perfusion showed B5-fold reduced osmotic water per-
meability in AQP1 deficiency, indicating AQP1 as a major
pathway for osmotically driven water movement across the
corneal endothelium. AQP1 appears to play an important
role in active extrusion of fluid from the corneal stroma
across the endothelium for maintenance of corneal transpar-
ency under stress. The recovery of corneal transparency and
thickness after hypotonic swelling (10 min exposure of
corneal surface to distilled water) was remarkably delayed
in AQP1-null mice, with B75% recovery at 7 min in wild-
type mice compared to only 5% recovery in AQP1-null mice.
Measurements in endothelial cells cultured from mouse
corneas of wild-type and AQP1-null mice confirmed the
reduced water permeability in AQP1 deficiency, and
suggested a potential role for AQP1 in corneal endothelial
cell volume regulation.14 In the trebecular meshwork,
measurements of intraocular pressure following pulsed fluid
infusions into the anterior chamber showed that AQP1 did
not facilitate aqueous fluid drainage,15 which is consistent
with the notion that aqueous fluid drainage involves
pressure-driven bulk fluid outflow.
AQP1 IN ANGIOGENESIS AND ENDOTHELIAL CELL MIGRA-
TION
AQP1 is expressed strongly in endothelial cells of proliferat-
ing microvessels in malignant tumors. Postulating the
possible involvement of AQP1 in tumor angiogenesis, we
found remarkably impaired tumor growth in AQP1-null
mice after subcutaneous or intracranial tumor cell implant-
ation (Figure 2a), with reduced tumor vascularity and
extensive necrosis surrounding islands of viable tumor cells
(Figure 2b).4 Reduced microvessel growth was also found in a
tumor-independent model in which angiogenesis was
measured in implanted pellets of Matrigel containing
endothelial growth factors. An unanticipated mechanism
for the impaired angiogenesis in AQP1 deficiency was
established from experiments on cultured aortic endothelial
cells from wild-type vs AQP1-null mice. Although cell
appearance, size, adhesion, and growth/proliferation were
similar, cell migration was greatly impaired in AQP1-
deficient endothelia (Figure 2c), with abnormal vessel
formation in vitro. As evidence that aquaporin-facilitated
cell migration might be a general phenomenon, we found
that stable transfection of non-endothelial cells with AQP1,
or a structurally different water-selective transporter (AQP4),
accelerated cell migration and in vitro wound healing.
Recently, we found aquaporin-dependent migration in
proximal tubule cells (AQP1, Hara-Chikuma and Verkman16)
and brain astroglia (AQP4, Saadoun et al.17), as well as
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Figure 2 | Impaired tumor angiogenesis and endothelial cell
migration in AQP1 deficiency. (a) Reduced tumor growth in AQP1-
null mice. (Left) Growth of subcutaneous melanoma in wild-type vs
AQP1-null mice. (Right) Survival of mice with subcutaneous
melanoma. (b) Tumor stained with isolectin-B4 (brown). Note islands
of tumor surrounded by necrotic tissue in AQP1-deficient mice. (c)
Impaired migration of endothelial cells lacking AQP1. (Left) Adhesion
and migration of endothelial cells quantified by counting cells in
Boyden chamber assay before and after scraping. (Right) Summary of
percentage of adherent and migrated cells. (d) (Left) Proposed
mechanism of AQP1-dependent cell migration, showing water influx
at the tip of a lamellipodium resulting in membrane protrusion in the
direction of cell migration. (Right) AQP1 (green, white arrow heads)
polarizes to lamellipodia in migrating AQP1-expressing CHO cells
(actin stained red).
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evidence for aquaporin involvement in wound healing and
tumor spread (unpublished results). Aquaporin-dependent
cell migration may thus be a general phenomenon not
restricted to vascular endothelial cells.
Figure 2d (left) shows our proposed mechanism for
aquaporin-dependent cell migration, in which membrane
protrusions (lamellipodia) at the leading edge of migrating
cells are formed as a consequence of actin cleavage and ion
uptake. Osmotic gradients then drive water influx through
the cell membrane, increasing local hydrostatic pressure
causing membrane protrusion. We propose that aquaporins
facilitate water entry into lamellipodia. In support of this
hypothesis, motile aquaporin-expressing cells show aqua-
porin polarization to lamellipodia (Figure 2d, right) and
increased lamellipodial dynamics; also, cell migration is
accelerated by small osmotic gradients driving water move-
ment from cell front-to-back, facilitating lamellipodial
extension at the front of the cell.4,16,17
PERSPECTIVE
Aquaporins and aquaglyceroporins play diverse roles in
mammalian biology, ranging from urinary concentrating
function and exocrine gland fluid secretion, to brain water
balance and neural signal transduction, glycerol/triglyceride
regulation in skin and fat, and cell migration (reviewed in
Verkman18). Although AQP1 is widely expressed in micro-
vascular endothelia outside of the brain, only in renal vasa
recta, where transendothelial and presumably transcellular
osmotic water transport is driven by solute gradients, is
AQP1 of clear functional significance in normal physiology.
Whether AQP1 might have functions in endothelia that are
unrelated to its water transport functions remains an open
question. AQP1-facilitated carbon dioxide transport has been
proposed, although studies in AQP1-null mice suggest that it
is of little physiological significance.19 Reduced angiogenesis
in AQP1-null mice and impaired migration of AQP1-
deficient endothelia suggests AQP1 involvement in rapid
vessel proliferation in tumors and following injury. In non-
vascular endothelia, AQP1 in intestinal lacteals facilitates
intestinal absorption,20 and AQP1 in corneal endothelium
appears to be quite important for corneal fluid balance,
although the precise mechanisms for these AQP1 functions
remain unclear. The phenotype studies suggest that
pharmacological AQP1 inhibition would induce diuresis in
heart failure and hypertension, reduce intraocular pressure
and corneal swelling, and inhibit tumor angiogenesis and
spread.
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